Triple Screen Pregnancy Test | Lahalak Medical Platform
A safe routine screening during the second trimester to evaluate fetal health and detect potential congenital defects, helping you monitor your pregnancy with complete awareness and peace of mind.
Scientific name: Triple Screen Test
Screening test (not diagnostic) performed on maternal blood sample between weeks 15 and 20 of pregnancy. Measures levels of three markers: Alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and unconjugated estriol (uE3). Results are combined with maternal age to estimate probability of fetal chromosomal disorders and neural tube defects.
Service type
Preventive Medical Screening (Blood)
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Performing the triple test (AFP, hCG, uE3) on the mother's serum.
- Consult a genetics or maternal-fetal medicine consultant to interpret the results.
- Personal support services from Halak.
Medical Service Information
Conditions & Notices
- Fasting: Not required.
- Precise timing: The sample should be taken between weeks 15 and 20 of pregnancy (optimum 16-18 weeks). Accuracy depends on knowing the exact gestational age (by ultrasound).
- Essential information: The laboratory must be provided with the gestational age in weeks, the mother's weight, age, presence of diabetes or smoking, and the number of fetuses.
- Understanding the results: It should be emphasized that the result is an estimate of the probability of risk, not a diagnosis.
Medical services you might also like
